36186136|t|P-Glycoprotein Aggravates Blood Brain Barrier Dysfunction in Experimental Ischemic Stroke by Inhibiting Endothelial Autophagy.
36186136|a|P-glycoprotein (P-gp) is expressed on brain microvessel endothelial cells of blood-brain barrier (BBB) and elevated after cerebral ischemia. In this study, we explored the influence and potential mechanisms of P-gp on BBB function in experimental ischemic stroke in vivo and in vitro. Middle cerebral artery occlusion/reperfusion (MCAO/R) was created in mice. Oxygen-glucose deprivation/reoxygenation (OGD/R) was performed in brain microvascular vessel-derived endothelial cells (bEnd.3) to mimic ischemia/reperfusion injury in vitro. P-gp-specific siRNA and pharmacological inhibitor cyclosporine A were used to inhibit P-gp, whereas pcDNA3.1 was utilized to overexpress P-gp. Twenty-four hours after reperfusion, acute ischemic stroke outcome, BBB integrity and permeability, autophagic proteins and relative signaling pathways were evaluated. P-gp levels were markedly elevated in mouse brain and endothelial cells following MCAO/R and OGD/R, respectively. P-gp siRNA silencing or pharmacologically inhibiting (cyclosporine A) reduced infarct volume and brain edema, attenuated brain pathology, and improved neurological behavior in association with attenuated accumulation of neutrophils and macrophages, reduced expression levels of inflammatory cytokines (TNF-alpha and IL-1beta), matrix metalloproteinases (MMP-2 and MMP-9) and adhesion molecules (ICAM-1 and VCAM-1). P-gp silence also counteracted BBB leakage, restored the expressions of tight junction proteins (Claudin-5, Occludin and ZO-1), activated autophagic proteins (upregulated LC3-II/LC3-I and Beclin 1, and downregulated P62), and diminished Akt/mTOR signal activity in mice following MCAO/R. In the endothelial cell OGD/R assay, P-gp silence downregulated the expressions of inflammatory cytokines and adhesion molecules, inhibited leukocytes adhesion and migration, increased tight junction protein levels, and activated autophagy, all were reversible by forceful P-gp expression. Additionally, treatment with an autophagy inhibitor (3-methyladenine) abolished protections against ischemic stroke and tight junction proteins reduction followed by P-gp silence. In conclusion, increased P-gp expression after ischemic injury resulted in BBB dysfunction and hyperpermeability by suppressing Akt/mTOR-induced endothelial autophagy.
36186136	32	57	Brain Barrier Dysfunction	Disease	MESH:D001927
36186136	74	89	Ischemic Stroke	Disease	MESH:D002544
36186136	143	147	P-gp	Gene	67078
36186136	249	266	cerebral ischemia	Disease	MESH:D002545
36186136	337	341	P-gp	Gene	67078
36186136	374	389	ischemic stroke	Disease	MESH:D002544
36186136	412	444	Middle cerebral artery occlusion	Disease	MESH:D020244
36186136	458	462	MCAO	Disease	
36186136	481	485	mice	Species	10090
36186136	487	493	Oxygen	Chemical	MESH:D010100
36186136	494	501	glucose	Chemical	MESH:D005947
36186136	624	632	ischemia	Disease	MESH:D007511
36186136	633	651	reperfusion injury	Disease	MESH:D015427
36186136	662	666	P-gp	Gene	67078
36186136	712	726	cyclosporine A	Chemical	MESH:D016572
36186136	748	752	P-gp	Gene	67078
36186136	799	803	P-gp	Gene	67078
36186136	848	863	ischemic stroke	Disease	MESH:D002544
36186136	973	977	P-gp	Gene	67078
36186136	1011	1016	mouse	Species	10090
36186136	1055	1059	MCAO	Disease	
36186136	1087	1091	P-gp	Gene	67078
36186136	1141	1155	cyclosporine A	Chemical	MESH:D016572
36186136	1165	1172	infarct	Disease	MESH:D007238
36186136	1184	1195	brain edema	Disease	MESH:D001929
36186136	1389	1398	TNF-alpha	Gene	21926
36186136	1403	1411	IL-1beta	Gene	16176
36186136	1441	1446	MMP-2	Gene	17390
36186136	1451	1456	MMP-9	Gene	17395
36186136	1482	1488	ICAM-1	Gene	15894
36186136	1493	1499	VCAM-1	Gene	22329
36186136	1502	1506	P-gp	Gene	67078
36186136	1599	1608	Claudin-5	Gene	12741
36186136	1610	1618	Occludin	Gene	18260
36186136	1623	1627	ZO-1	Gene	21872
36186136	1680	1683	LC3	Gene	66734
36186136	1690	1698	Beclin 1	Gene	56208
36186136	1718	1721	P62	Gene	18226
36186136	1739	1742	Akt	Gene	11651
36186136	1743	1747	mTOR	Gene	56717
36186136	1767	1771	mice	Species	10090
36186136	1782	1786	MCAO	Disease	
36186136	1827	1831	P-gp	Gene	67078
36186136	2063	2067	P-gp	Gene	67078
36186136	2133	2148	3-methyladenine	Chemical	MESH:C025946
36186136	2180	2195	ischemic stroke	Disease	MESH:D002544
36186136	2246	2250	P-gp	Gene	67078
36186136	2285	2289	P-gp	Gene	67078
36186136	2307	2322	ischemic injury	Disease	MESH:D017202
36186136	2335	2350	BBB dysfunction	Disease	MESH:C536830
36186136	2388	2391	Akt	Gene	11651
36186136	2392	2396	mTOR	Gene	56717
36186136	Negative_Correlation	MESH:C025946	67078
36186136	Association	56208	67078
36186136	Negative_Correlation	MESH:D016572	MESH:D007238
36186136	Negative_Correlation	MESH:D016572	22329
36186136	Negative_Correlation	MESH:D016572	16176
36186136	Negative_Correlation	MESH:D016572	17390
36186136	Positive_Correlation	22329	67078
36186136	Negative_Correlation	MESH:D005947	MESH:D007511
36186136	Positive_Correlation	17390	67078
36186136	Positive_Correlation	17395	67078
36186136	Negative_Correlation	MESH:D016572	17395
36186136	Association	MESH:D007238	67078
36186136	Positive_Correlation	15894	67078
36186136	Positive_Correlation	11651	67078
36186136	Association	MESH:D005947	MESH:D010100
36186136	Negative_Correlation	MESH:D005947	MESH:D015427
36186136	Negative_Correlation	MESH:D016572	MESH:D001929
36186136	Association	18260	67078
36186136	Association	MESH:D001929	67078
36186136	Association	66734	67078
36186136	Negative_Correlation	MESH:D016572	21926
36186136	Negative_Correlation	MESH:D016572	15894
36186136	Positive_Correlation	MESH:D002545	67078
36186136	Negative_Correlation	MESH:D010100	MESH:D007511
36186136	Positive_Correlation	21926	67078
36186136	Positive_Correlation	16176	67078
36186136	Negative_Correlation	MESH:C025946	MESH:D002544
36186136	Negative_Correlation	MESH:D016572	67078
36186136	Positive_Correlation	56717	67078
36186136	Positive_Correlation	18226	67078
36186136	Positive_Correlation	12741	67078
36186136	Association	21872	67078

